Russian Prime Minister Signs Decree on Tobacco Product Marking Expansion

Regulations by 2FIRSTS.ai
Mar.08.2024
Russian Prime Minister Signs Decree on Tobacco Product Marking Expansion
Russian Prime Minister Mikhail Mishustin has signed a decree expanding the scope of tobacco product labeling, aimed at reducing illegal production.

According to Russian media outlet Lenta, Russian Prime Minister Mikhail Mishustin has signed a decree to expand the scope of labeling for tobacco products. Under this decree, all raw materials used in the production of tobacco and nicotine-containing products must be labeled.

 

This resolution is a part of efforts to reduce the illegal production of tobacco and other nicotine-containing products. It is reported that most of the provisions of this resolution will take effect within 30 days, with some provisions, such as the refusal to issue identification codes, taking effect on July 1st.

 

In 2019, Russia began implementing digital marking on tobacco products, and starting from February 1, 2022, fines will be imposed on individuals carrying unmarked tobacco products exceeding 200 cigarettes or 50 cigars. By October 2023, the regulations will extend to unmarked e-cigarettes and the transportation of e-cigarettes.

 

According to Ekaterina Priyezheva, Deputy Minister of Industry and Trade of Russia, over the past three years, cracking down on the illegal trafficking of tobacco products through labeling has generated an additional 245 billion rubles (approximately 2.7 billion US dollars) in revenue for the country.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco to close South Africa cigarette plant by end-2026, citing illicit trade squeezing legal market
British American Tobacco South Africa (BATSA) said it will halt local production of factory-made cigarettes and close its manufacturing plant in Heidelberg, Gauteng by the end of 2026, shifting to an import-led supply model. The company said illicit cigarettes now account for about 75% of South Africa’s market, making local manufacturing “unsustainable” and putting around 230 jobs at risk.
Jan.16
Spain’s new e-cigarette e-liquid tax, in force since April 1, raises €26 million through November
Spain’s new e-cigarette e-liquid tax, in force since April 1, raises €26 million through November
Spain’s Tax Agency monthly collection report shows the new tax on e-cigarette e-liquids, in force since April 1, raised €26 million through November, including €4 million in November. The levy began three months later than the usual fiscal timetable to allow the sector to adapt, making 2025 the first year in which vaping products are taxed under a specific category.
Dec.30 by 2FIRSTS.ai
China’s Nov. Vape Exports to U.S. Hold at $549 Million, Sustaining High After October’s $591 Million Peak
China’s Nov. Vape Exports to U.S. Hold at $549 Million, Sustaining High After October’s $591 Million Peak
China’s Nov. vape exports to the U.S. held at $549 million, following October’s $591 million record. 2025 YTD exports reached $3.72 billion, officially eclipsing 2024’s full-year total. This $1.14 billion 60-day surge signals a critical inventory overhang, heightening financial and regulatory risks for manufacturers.
Dec.22
Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
Singapore man, 21, assisting investigations after video allegedly shows him vaping on a bus
A 21-year-old man in Singapore is assisting with investigations after a video allegedly showing him vaping inside a bus went viral on social media. The Health Sciences Authority (HSA) said via its Instagram Stories that it had identified the man and seized e-vaporisers and 12 pods from his home on Feb 3. Vape-related penalties were strengthened from Sept 1, with first-time adult users liable to a $700 fine, and third-time offenders prosecuted and fined up to $2,000.
Feb.06
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
FDA PMTA Roundtable: Ongoing Comprehensive Coverage by 2Firsts
Feb.11
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework
At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.
Feb.11